Enhanced External Counter Pulsation (EECP) is a US FDA-approved, non-invasive therapy designed to enhance blood flow to the heart and brain by promoting the development of collateral circulation. It is recognized as a Class IIb recommendation by the American College of Cardiology (ACC) and the American Heart Association (AHA) for patients with refractory angina and heart failure.

The Only Viable Option for Certain High-Risk Cardiac Patients

For patients who are medically unfit or unwilling to undergo bypass surgery or angioplasty, EECP stands as the only proven non-invasive treatment option available. This includes individuals with:

• Severe co-morbidities (e.g., kidney failure, uncontrolled diabetes)

• Advanced age

• History of multiple previous surgeries or interventions

• Diffuse coronary artery disease not amenable to stenting or grafting

EECP offers these patients a safe, outpatient-based alternative that significantly improves blood flow to ischemic areas of the heart without the risks of invasive procedures.

The main advantages of the treatment are :

1. Non-Invasive, Outpatient-Based Therapy
   EECP is completely non-surgical, requires no hospitalization or anesthesia, and is well-tolerated even by elderly or high-risk patients.

2. US FDA-Approved & Internationally Recommended

   • Approved by the U.S. Food and Drug Administration (FDA) for the treatment of chronic stable angina and heart failure.

   • Recognized as a Class IIb recommendation by the American College of Cardiology (ACC) and the American Heart Association (AHA).

   • CE certified in Europe.

3. Improves Ejection Fraction (EF)
   EECP has been shown to significantly improve left ventricular function in heart failure patients.
   ▶️ At Hridaya Care Heart Institute, we have documented remarkable improvement in ejection fraction (EF)—including cases where patients with an EF as low as 25% improved to over 60–65% following a structured course of EECP therapy.
   These outcomes were achieved without surgery, using only non-invasive treatment and guided medical support.

4. The Only Proven Non-Invasive Option for Patients Unsuitable for Bypass or Angioplasty
   EECP is often the only effective treatment for patients who cannot undergo invasive procedures due to:

   • Severe comorbidities

   • Renal dysfunction

   • Advanced age

   • Diffuse coronary artery disease

   • Prior failed surgeries or high-risk profile

5. Relieves Refractory Angina and Heart Failure Symptoms

   • Reduces angina episodes, breathlessness, and fatigue

   • Improves quality of life and daily functioning

6. Can Delay or Eliminate the Need for Bypass Surgery or Angioplasty
   In many patients, EECP helps stabilize symptoms and improve perfusion, thus avoiding or deferring the need for invasive interventions.

7. Enhances Cerebral Circulation – Stroke Recovery Support
   Beneficial in post-stroke patients, EECP helps restore cerebral perfusion, improving alertness, motor strength, and functional recovery.

8. Preventive Therapy in High-Risk Individuals
   Can be administered safely in asymptomatic individuals with risk factors (e.g., diabetes, stress, family history) to promote cardiovascular health and prevent future disease.